Rhythm Pharmaceuticals (RYTM) Retained Earnings (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Retained Earnings of $444000.0 for Q1 2026, up 100.04% year-over-year from $221958.9 in Q1 2025, and down 99.97% quarter-over-quarter from $1.5 billion in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Retained Earnings (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Retained Earnings for 11 consecutive years, with $444000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 100.04% year-over-year to $444000.0; the TTM figure through Mar 2026 stood at $444000.0 (up 100.04% YoY), while the FY2025 annual figure was $1.5 billion, up 3824907.69% from the prior year.
- Retained Earnings fell to $444000.0 in Q1 2026 per RYTM's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.5 billion in Q4 2025 and bottomed at -$1.3 billion in Q3 2025.
- Historically, Retained Earnings has averaged $191.5 million across 5 years, with a median of $134000.0 in 2023.
- On a YoY basis, Retained Earnings climbed as much as 3824907.69% in 2025 and fell as far as 662883.43% in 2025.
- Rhythm Pharmaceuticals' Retained Earnings stood at -$92000.0 in 2022, then surged by 245.65% to $134000.0 in 2023, then tumbled by 129.1% to -$39000.0 in 2024, then jumped by 3824907.69% to $1.5 billion in 2025, then plunged by 99.97% to $444000.0 in 2026.
- Business Quant data shows RYTM's Retained Earnings at $444000.0 in Q1 2026, $1.5 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 1.56 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Bn |
| Mar 31, 2026 | 444,000.00 |
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | -1.30 Bn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | -39,000.00 |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | -1.07 Bn |
| Mar 31, 2024 | -181,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 991.18 Mn |
| Mar 31, 2023 | 981.95 Mn |
| Dec 31, 2022 | -92,000.00 |
| Sep 30, 2022 | 949.04 Mn |
| Jun 30, 2022 | 823.19 Mn |
| Mar 31, 2022 | -581.70 Mn |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 808.27 Mn |